Background The emergence and spread of high levels of HIV-1 drug resistance in resource-limited
settings where combination antiretroviral treatment has been scaled up could …

We report the second human immunodeficiency virus (HIV) belonging to the new HIV type 1
(HIV-1) group P lineage that is closely related to the simian immunodeficiency virus found in …

Background Global genetic diversity of HIV-1 is a major challenge to the development of HIV
vaccines. We aimed to estimate the regional and global distribution of HIV-1 subtypes and …

Background Identification of new ways to increase access to antiretroviral therapy in Africa
is an urgent priority. We assessed whether home-based HIV care was as effective as was …

Background Regional and subtype-specific mutational patterns of HIV-1 transmitted drug
resistance (TDR) are essential for informing first-line antiretroviral (ARV) therapy guidelines …

Background Antiretroviral therapy (ART) is crucial for controlling HIV-1 infection through
wide-scale treatment as prevention and pre-exposure prophylaxis (PrEP). Potent tenofovir …

Blood samples (n=544) from two different populations (Pygmies and Bantus) in Cameroon,
West Africa, were analysed. Serological tests indicated that the anti-hepatitis C virus (HCV) …

Background: HIV-1 strains have diversified extensively through mutation and recombination
since their initial transmission to human beings many decades ago in Central Africa in the …

… Nicaise Ndembi … Nicaise Ndembi … Nicaise Ndembi is a senior science adviser at the
Africa Centers for Disease Control and Prevention, Addis Ababa, Ethiopia. …

Metagenomic next-generation sequencing (mNGS), the shotgun sequencing of RNA and
DNA from clinical samples, has proved useful for broad-spectrum pathogen detection and the …